U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Decreased lymphocyte proliferation in response to anti-CD3

MedGen UID:
1614554
Concept ID:
C4531165
Finding
Synonyms: Defective lymphocyte proliferation to anti-CD3; Defective proliferation of lymphocytes following anti-CD3 stimulation
 
HPO: HP:0031382

Definition

A decreased proliferative response of lymphocytes in vitro or in vivo, when stimulated with an anti-CD3 antibody against the T-cell co-receptor, CD3. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVDecreased lymphocyte proliferation in response to anti-CD3

Conditions with this feature

T-B+ severe combined immunodeficiency due to JAK3 deficiency
MedGen UID:
331474
Concept ID:
C1833275
Disease or Syndrome
JAK3-deficient severe combined immunodeficiency (SCID) is an inherited disorder of the immune system. Individuals with JAK3-deficient SCID lack the necessary immune cells to fight off certain bacteria, viruses, and fungi. They are prone to repeated and persistent infections that can be very serious or life-threatening. Often the organisms that cause infection in people with JAK3-deficient SCID are described as opportunistic because they ordinarily do not cause illness in healthy people. Affected infants typically develop chronic diarrhea, a fungal infection in the mouth called oral thrush, pneumonia, and skin rashes. Persistent illness also causes affected individuals to grow more slowly than other children. Without treatment, people with JAK3-deficient SCID usually live only into early childhood.
Immunodeficiency due to CD25 deficiency
MedGen UID:
377894
Concept ID:
C1853392
Disease or Syndrome
Immunodeficiency-41 is an autosomal recessive complex disorder of immune dysregulation. Affected individuals present in infancy with recurrent viral, fungal, and bacterial infections, lymphadenopathy, and variable autoimmune features, such as autoimmune enteropathy and eczematous skin lesions. Immunologic studies show a defect in T-cell regulation (summary by Goudy et al., 2013).
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
MedGen UID:
481620
Concept ID:
C3279990
Disease or Syndrome
IMD31C is a disorder of immunologic dysregulation with highly variable manifestations resulting from autosomal dominant gain-of-function mutations in STAT1 (600555). Most patients present in infancy or early childhood with chronic mucocutaneous candidiasis (CMC). Other highly variable features include recurrent bacterial, viral, fungal, and mycoplasmal infections, disseminated dimorphic fungal infections, enteropathy with villous atrophy, and autoimmune disorders, such as hypothyroidism or diabetes mellitus. A subset of patients show apparently nonimmunologic features, including osteopenia, delayed puberty, and intracranial aneurysms. Laboratory studies show increased activation of gamma-interferon (IFNG; 147570)-mediated inflammation (summary by Uzel et al., 2013 and Sampaio et al., 2013).
Combined immunodeficiency due to MALT1 deficiency
MedGen UID:
815913
Concept ID:
C3809583
Disease or Syndrome
Combined immunodeficiency due to MALT1 deficiency is a rare, genetic form of primary immunodeficiency characterized by growth retardation, early recurrent pulmonary infections leading to bronchiectasis, inflammatory gastrointestinal disease, and other symptoms, such as rash, dermatitis, skin infections.
Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia
MedGen UID:
1740566
Concept ID:
C5436549
Disease or Syndrome
Immunodeficiency-73B with defective neutrophil chemotaxis (IMD73B) is an autosomal dominant immunologic disorder characterized by onset of recurrent infections in infancy or early childhood. Affected individuals develop respiratory infections, cellulitis, and severe invasive infections or sepsis; organisms include bacteria such as Staphylococcus, as well as viruses, fungi, and mycobacterial species. Laboratory studies show variable abnormalities, including B- and T-cell lymphopenia, decreased immunoglobulin subsets, decreased TRECs and dysfunctional T cells, decreased NK cells, neutropenia, and impaired neutrophil chemotaxis. Hematopoietic stem cell transplantation is curative (summary by Hsu et al., 2019; review by Lougaris et al., 2020). In a review of autosomal forms of chronic granulomatous disease (see 306400 for genetic heterogeneity of CGD), Roos et al. (2021) noted that patients with RAC2 mutations may manifest CGD-like symptoms due to defects in neutrophil NADPH oxidase activity.
Immunodeficiency 80 with or without congenital cardiomyopathy
MedGen UID:
1786417
Concept ID:
C5543344
Disease or Syndrome
Immunodeficiency-80 with or without congenital cardiomyopathy (IMD80) is an autosomal recessive immunologic disorder with variable manifestations. One patient with infantile-onset of chronic cytomegalovirus (CMV) infection associated with severely decreased NK cells has been reported. Another family with 3 affected fetuses showing restrictive cardiomyopathy and hypoplasia of the spleen and thymus has also been reported (summary by Baxley et al., 2021).
Atelis syndrome 1
MedGen UID:
1824054
Concept ID:
C5774281
Disease or Syndrome
Atelis syndrome-1 (ATELS1) is an autosomal recessive neurodevelopmental disorder characterized by global developmental delay with learning difficulties and poor overall growth with short stature and microcephaly. Most patients have anemia, some have immunologic defects, and some have congenital heart septal defects. More variable features may include hypotonia, dysmorphic facial features, skin pigmentary anomalies, and mild skeletal defects. Patient cells show multiple chromosomal abnormalities due to impaired DNA replication and disrupted mitosis (Grange et al., 2022). See also ATELS2 (620185), caused by mutation in the SMC5 gene (609386) on chromosome 9q21. For a discussion of genetic heterogeneity of MVA, see MVA1 (257300).
Immunodeficiency 109 with lymphoproliferation
MedGen UID:
1840982
Concept ID:
C5830346
Disease or Syndrome
Immunodeficiency-109 with EBV-induced lymphoproliferation (IMD109) is an autosomal recessive primary immune disorder characterized by onset of recurrent sinopulmonary infections in childhood. Affected individuals are susceptible to infection with EBV and develop EBV viremia and EBV-associated lymphoproliferative disease or B-cell lymphoma. Immunologic work-up shows normal levels of T, B, and NK cells, with defective CD8+ T cell function after stimulation. Some patients may have hypogammaglobulinemia and poor antibody response to stimulation (Alosaimi et al., 2019).

Professional guidelines

PubMed

Cannon GW, Marble DA, Griffiths MM, Cole BC, McCall S, Schulman SF, Strand V
J Rheumatol 1995 Feb;22(2):207-13. PMID: 7537827
Salmaggi A, Baldetorp B, Milanese C, Nespolo A, Parma R, Sandberg-Wollheim M
Acta Neurol Scand 1991 Aug;84(2):91-7. doi: 10.1111/j.1600-0404.1991.tb04914.x. PMID: 1835240
Weil-Hillman G, Schell K, Segal DM, Hank JA, Sosman JA, Sondel PM
J Immunother (1991) 1991 Aug;10(4):267-77. doi: 10.1097/00002371-199108000-00005. PMID: 1834166

Recent clinical studies

Etiology

Godefroy E, Alameddine J, Montassier E, Mathé J, Desfrançois-Noël J, Marec N, Bossard C, Jarry A, Bridonneau C, Le Roy A, Sarrabayrouse G, Kerdreux E, Bourreille A, Sokol H, Jotereau F, Altare F
Gastroenterology 2018 Oct;155(4):1205-1217. Epub 2018 Jul 5 doi: 10.1053/j.gastro.2018.06.078. PMID: 29981781
Domouchtsidou A, Barsegian V, Mueller SP, Best J, Ertle J, Bedreli S, Horn PA, Bockisch A, Lindemann M
Cancer Immunol Immunother 2018 May;67(5):843-853. Epub 2018 Mar 2 doi: 10.1007/s00262-018-2141-0. PMID: 29500633Free PMC Article
Poujol F, Monneret G, Gallet-Gorius E, Pachot A, Textoris J, Venet F
Immunol Invest 2018 Feb;47(2):154-168. Epub 2017 Nov 28 doi: 10.1080/08820139.2017.1407786. PMID: 29182416
Poujol F, Monneret G, Pachot A, Textoris J, Venet F
PLoS One 2015;10(12):e0144375. Epub 2015 Dec 7 doi: 10.1371/journal.pone.0144375. PMID: 26642057Free PMC Article
Moro-García MA, Alonso-Arias R, López-Vázquez A, Suárez-García FM, Solano-Jaurrieta JJ, Baltar J, López-Larrea C
Age (Dordr) 2012 Apr;34(2):479-95. Epub 2011 Apr 13 doi: 10.1007/s11357-011-9240-6. PMID: 21487706Free PMC Article

Diagnosis

Lamas B, Martins Breyner N, Malaisé Y, Wulczynski M, Galipeau HJ, Gaultier E, Cartier C, Verdu EF, Houdeau E
Environ Health Perspect 2024 Feb;132(2):27007. Epub 2024 Feb 21 doi: 10.1289/EHP12758. PMID: 38380914Free PMC Article
Belaid B, Lamara Mahammed L, Mohand Oussaid A, Migaud M, Khadri Y, Casanova JL, Puel A, Ben Halla N, Djidjik R
Front Immunol 2021;12:696350. Epub 2021 Jun 24 doi: 10.3389/fimmu.2021.696350. PMID: 34248995Free PMC Article
Zibandeh N, Genc D, Duran Y, Banzragch M, Sokwala S, Goker K, Atug O, Akkoç T
Turk J Gastroenterol 2020 May;31(5):400-409. doi: 10.5152/tjg.2020.19358. PMID: 32519960Free PMC Article
Godefroy E, Alameddine J, Montassier E, Mathé J, Desfrançois-Noël J, Marec N, Bossard C, Jarry A, Bridonneau C, Le Roy A, Sarrabayrouse G, Kerdreux E, Bourreille A, Sokol H, Jotereau F, Altare F
Gastroenterology 2018 Oct;155(4):1205-1217. Epub 2018 Jul 5 doi: 10.1053/j.gastro.2018.06.078. PMID: 29981781
Giacomelli M, Kumar R, Soresina A, Tamassia N, Lorenzini T, Moratto D, Gasperini S, Cassatella M, Plebani A, Lougaris V, Badolato R
J Allergy Clin Immunol 2016 Jul;138(1):229-240.e3. Epub 2016 Feb 11 doi: 10.1016/j.jaci.2015.10.051. PMID: 26875746

Therapy

Guo J, Li B, Wang J, Guo R, Tian Y, Song S, Guo L
Int Immunopharmacol 2021 Sep;98:107846. Epub 2021 Jun 23 doi: 10.1016/j.intimp.2021.107846. PMID: 34174704
Domouchtsidou A, Barsegian V, Mueller SP, Best J, Ertle J, Bedreli S, Horn PA, Bockisch A, Lindemann M
Cancer Immunol Immunother 2018 May;67(5):843-853. Epub 2018 Mar 2 doi: 10.1007/s00262-018-2141-0. PMID: 29500633Free PMC Article
Xu S, Zuo A, Guo Z, Wan C
J Immunol Res 2017;2017:7416792. Epub 2017 Jun 15 doi: 10.1155/2017/7416792. PMID: 28706956Free PMC Article
Tooley JE, Vudattu N, Choi J, Cotsapas C, Devine L, Raddassi K, Ehlers MR, McNamara JG, Harris KM, Kanaparthi S, Phippard D, Herold KC
Eur J Immunol 2016 Jan;46(1):230-41. Epub 2015 Dec 14 doi: 10.1002/eji.201545708. PMID: 26518356Free PMC Article
Xynos ID, Karadima ML, Voutsas IF, Amptoulach S, Skopelitis E, Kosmas C, Gritzapis AD, Tsavaris N
Oncology 2013;84(5):273-83. Epub 2013 Feb 22 doi: 10.1159/000343282. PMID: 23445638

Prognosis

Siemińska I, Węglarczyk K, Surmiak M, Kurowska-Baran D, Sanak M, Siedlar M, Baran J
Front Immunol 2021;12:748097. Epub 2021 Sep 29 doi: 10.3389/fimmu.2021.748097. PMID: 34659245Free PMC Article
Godefroy E, Alameddine J, Montassier E, Mathé J, Desfrançois-Noël J, Marec N, Bossard C, Jarry A, Bridonneau C, Le Roy A, Sarrabayrouse G, Kerdreux E, Bourreille A, Sokol H, Jotereau F, Altare F
Gastroenterology 2018 Oct;155(4):1205-1217. Epub 2018 Jul 5 doi: 10.1053/j.gastro.2018.06.078. PMID: 29981781
Domouchtsidou A, Barsegian V, Mueller SP, Best J, Ertle J, Bedreli S, Horn PA, Bockisch A, Lindemann M
Cancer Immunol Immunother 2018 May;67(5):843-853. Epub 2018 Mar 2 doi: 10.1007/s00262-018-2141-0. PMID: 29500633Free PMC Article
Xynos ID, Karadima ML, Voutsas IF, Amptoulach S, Skopelitis E, Kosmas C, Gritzapis AD, Tsavaris N
Oncology 2013;84(5):273-83. Epub 2013 Feb 22 doi: 10.1159/000343282. PMID: 23445638
Gajewski TF, Schell SR, Nau G, Fitch FW
Immunol Rev 1989 Oct;111:79-110. doi: 10.1111/j.1600-065x.1989.tb00543.x. PMID: 2534116

Clinical prediction guides

Guillerey C, Harjunpää H, Carrié N, Kassem S, Teo T, Miles K, Krumeich S, Weulersse M, Cuisinier M, Stannard K, Yu Y, Minnie SA, Hill GR, Dougall WC, Avet-Loiseau H, Teng MWL, Nakamura K, Martinet L, Smyth MJ
Blood 2018 Oct 18;132(16):1689-1694. Epub 2018 Jul 9 doi: 10.1182/blood-2018-01-825265. PMID: 29986909
Dukovska D, Fernández-Soto D, Valés-Gómez M, Reyburn HT
Front Immunol 2018;9:390. Epub 2018 Mar 1 doi: 10.3389/fimmu.2018.00390. PMID: 29545803Free PMC Article
Poujol F, Monneret G, Gallet-Gorius E, Pachot A, Textoris J, Venet F
Immunol Invest 2018 Feb;47(2):154-168. Epub 2017 Nov 28 doi: 10.1080/08820139.2017.1407786. PMID: 29182416
Hoetzenecker K, Hacker S, Hoetzenecker W, Sadeghi K, Sachet M, Pollreisz A, Mangold A, Wliszczak T, Bielek E, Muehlbacher F, Klepetko W, Ankersmit HJ
Eur J Clin Invest 2007 Dec;37(12):978-86. doi: 10.1111/j.1365-2362.2007.01881.x. PMID: 18036032
Gajewski TF, Schell SR, Nau G, Fitch FW
Immunol Rev 1989 Oct;111:79-110. doi: 10.1111/j.1600-065x.1989.tb00543.x. PMID: 2534116

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...